dc.creator | Sagris D., Harrison S.L., Lip G.Y.H. | en |
dc.date.accessioned | 2023-01-31T09:52:39Z | |
dc.date.available | 2023-01-31T09:52:39Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1371/journal.pmed.1004067 | |
dc.identifier.issn | 15491277 | |
dc.identifier.uri | http://hdl.handle.net/11615/78659 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | PLoS Medicine | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136339741&doi=10.1371%2fjournal.pmed.1004067&partnerID=40&md5=1a1f6711f91f174931725cab583097ab | |
dc.subject | hemoglobin A1c | en |
dc.subject | high density lipoprotein cholesterol | en |
dc.subject | lipid | en |
dc.subject | low density lipoprotein cholesterol | en |
dc.subject | triacylglycerol | en |
dc.subject | lipid | en |
dc.subject | acute heart infarction | en |
dc.subject | Article | en |
dc.subject | atrial fibrillation | en |
dc.subject | cardiovascular risk | en |
dc.subject | coronary artery disease | en |
dc.subject | dyslipidemia | en |
dc.subject | heart failure | en |
dc.subject | human | en |
dc.subject | hyperlipidemia | en |
dc.subject | hypertension | en |
dc.subject | physical activity | en |
dc.subject | prevalence | en |
dc.subject | randomized controlled trial (topic) | en |
dc.subject | risk factor | en |
dc.subject | sensitivity analysis | en |
dc.subject | atrial fibrillation | en |
dc.subject | Atrial Fibrillation | en |
dc.subject | Humans | en |
dc.subject | Lipids | en |
dc.subject | Public Library of Science | en |
dc.title | Lipids and atrial fibrillation: New insights into a paradox | en |
dc.type | journalArticle | en |